Substrate degradation by the ubiquitin proteasome system (UPS) in specific membrane compartments remains elusive. Here, we show that the interplay of two lipid modifications and PDE68 regulates compart-mental substrate targeting via the SCFFBXL2. FBXL2 is palmitoylated in a prenylation-dependent manner on cysteines 417 and 419 juxtaposed to the CaaX motif. Palmitoylation/depalmitoylation regulates its subcel-lular trafficking for substrate engagement and degradation. To control its subcellular distribution, lipid -modi-fied FBXL2 interacts with PDE68. Perturbing the equilibrium between FBXL2 and PDE68 disrupts the delivery of FBXL2 to all membrane compartments, whereas depalmitoylated FBXL2 is enriched on the endoplasmic reticulum (ER). Depalmitoylated FBXL2(C417S/C419S) promotes the degradation of IP3R3 at the ER, inhibits IP3R3-dependent mitochondrial calcium overload, and counteracts calcium-dependent cell death upon oxidative stress. In contrast, disrupting the PDE68-FBXL2 equilibrium has the opposite effect. These findings describe a mechanism underlying spatially-restricted substrate degradation and suggest that inhibition of FBXL2 palmitoylation and/or binding to PDE68 may offer therapeutic benefits.
Palmitoylation and PDE6δ regulate membrane-compartment-specific substrate ubiquitylation and degradation
Lauriola, Angela;Guardavaccaro, Daniele;
2023-01-01
Abstract
Substrate degradation by the ubiquitin proteasome system (UPS) in specific membrane compartments remains elusive. Here, we show that the interplay of two lipid modifications and PDE68 regulates compart-mental substrate targeting via the SCFFBXL2. FBXL2 is palmitoylated in a prenylation-dependent manner on cysteines 417 and 419 juxtaposed to the CaaX motif. Palmitoylation/depalmitoylation regulates its subcel-lular trafficking for substrate engagement and degradation. To control its subcellular distribution, lipid -modi-fied FBXL2 interacts with PDE68. Perturbing the equilibrium between FBXL2 and PDE68 disrupts the delivery of FBXL2 to all membrane compartments, whereas depalmitoylated FBXL2 is enriched on the endoplasmic reticulum (ER). Depalmitoylated FBXL2(C417S/C419S) promotes the degradation of IP3R3 at the ER, inhibits IP3R3-dependent mitochondrial calcium overload, and counteracts calcium-dependent cell death upon oxidative stress. In contrast, disrupting the PDE68-FBXL2 equilibrium has the opposite effect. These findings describe a mechanism underlying spatially-restricted substrate degradation and suggest that inhibition of FBXL2 palmitoylation and/or binding to PDE68 may offer therapeutic benefits.File | Dimensione | Formato | |
---|---|---|---|
Liang et al.pdf
accesso aperto
Licenza:
Dominio pubblico
Dimensione
3.13 MB
Formato
Adobe PDF
|
3.13 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.